Edge Wealth Management’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-100
Closed -$2K 563
2017
Q3
$2K Hold
100
﹤0.01% 491
2017
Q2
$2K Sell
100
-50
-33% -$1.1K ﹤0.01% 483
2017
Q1
$3K Sell
150
-1
-0.7% -$22 ﹤0.01% 438
2016
Q4
$4K Hold
151
﹤0.01% 403
2016
Q3
$4K Hold
151
﹤0.01% 405
2016
Q2
$4K Hold
151
﹤0.01% 377
2016
Q1
$5K Buy
+151
New +$4.75K ﹤0.01% 344

Other funds holding PGEN

Edge Wealth Management's PGEN Position: Q4 2017 in Review

Edge Wealth Management sold out of Precigen (PGEN) in Q4 2017, closing a stake of 100 shares — an estimated $2K sold.

Edge Wealth Management first reported a position in PGEN in Q1 2016 and held it in 7 quarters. The position peaked at $5K in Q1 2016. 162 funds tracked by Wall St. Rank hold PGEN as of Q4 2017.

  • Edge Wealth Management reported no remaining Precigen position as of Q4 2017 after selling out during the quarter.
  • Edge Wealth Management sold 100 Precigen shares in Q4 2017, an estimated $2K.
  • Edge Wealth Management first reported a position in Precigen in Q1 2016 and held it in 7 quarters.
  • Edge Wealth Management's Precigen position peaked at $5K in Q1 2016.
  • 162 funds tracked by Wall St. Rank held Precigen as of Q4 2017.

Based on Edge Wealth Management's 13F filing for Q4 2017, filed 18 Jan 2018.